$Belimumab ameliorates symptoms and disease activity in patients with dermatomyositis and juvenile dermatomyositis refractory to standard therapy: A retrospective observational study$

Belimumab ameliorates symptoms and disease activity in patients with dermatomyositis and juvenile dermatomyositis refractory to standard therapy: A retrospective observational study

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American Academy of Dermatology 2024-09, Vol.91 (3), p.524-527
Hauptverfasser:	Liu, Yu, Li, Yongzhen, Shen, Tian, Zhang, Huiming, Luo, Shuangyan, Zhang, Qing, Dang, Xiqiang, Li, Xiaoyan, Long, Hai
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Antibodies, Monoclonal, Humanized - therapeutic use B cell activating factor (BAFF) belimumab B lymphocyte stimulator (BLyS) Child dermatomyositis Dermatomyositis - complications Dermatomyositis - drug therapy Female Humans Immunosuppressive Agents - therapeutic use juvenile dermatomyositis Male Middle Aged Myositis Intention-to-Treat Activity Index (MITAX) Retrospective Studies Severity of Illness Index Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:
ISSN:	0190-9622 1097-6787 1097-6787
DOI:	10.1016/j.jaad.2024.04.060